Drug Calibration Patents Under Scrutiny As Supreme Court Weighs How To Build On Law Of Nature

During oral arguments in Mayo v. Prometheus, justices question what standard to apply in assessing whether the correlation of a drug’s metabolites to proper dosage is patentable; ACLU petitions court to review Myriad gene patent case.

More from Legal & IP

More from Pink Sheet